1. Therapeutic potential of human minor salivary gland epithelial progenitor cells in liver regeneration.
- Author
-
Zhang C, Li Y, Zhang XY, Liu L, Tong HZ, Han TL, Li WD, Jin XL, Yin NB, Song T, Li HD, Zhi J, Zhao ZM, and Lu L
- Subjects
- Acute Lung Injury chemically induced, Animals, Carbon Tetrachloride toxicity, Cell Differentiation genetics, Cell Self Renewal genetics, Epithelial Cells transplantation, Gene Expression Regulation, Developmental, Hepatocytes drug effects, Hepatocytes pathology, Humans, Liver growth & development, Liver metabolism, Mesenchymal Stem Cells cytology, Mice, Salivary Glands, Minor cytology, Stem Cells cytology, Acute Lung Injury drug therapy, Cell- and Tissue-Based Therapy, Liver Regeneration genetics, Mesenchymal Stem Cell Transplantation, Salivary Glands, Minor transplantation
- Abstract
Liver disease is a serious problem affecting millions of people with continually increasing prevalence. Stem cell therapy has become a promising treatment for liver dysfunction. We previously reported on human minor salivary gland mesenchymal stem cells (hMSGMSCs), which are highly self-renewable with multi-potent differentiation capability. In this study, keratinocyte-like cells with self-regeneration and hepatic differentiation potential were isolated and characterized, and named human minor salivary gland epithelial progenitor cells (hMSG-EpiPCs). hMSG-EpiPCs were easily obtained via minor intraoral incision; they expressed epithelial progenitor/stem cell and other tissue stem cell markers such as CD29, CD49f, cytokeratins, ABCG2, PLET-1, salivary epithelial cell markers CD44 and CD166, and the Wnt target related gene LGR5 and LGR6. The cells were induced into functional hepatocytes in vitro which expressed liver-associated markers ALB, CYP3A4, AAT, and CK18. Upon transplantation in vivo, they ameliorated severe acute liver damage in SCID mice caused by carbon tetrachloride (CCl
4 ) injection. In a two-thirds partial hepatectomy mouse model, the transplanted cells survived at least 4 weeks and exhibited hepatic potential. These findings demonstrate that hMSG-EpiPCs have potential as a cellular therapy basis for hepatic diseases, physiological and toxicology studies and regenerative medicine.- Published
- 2017
- Full Text
- View/download PDF